Joan Besalduch Selected Research

Joan Besalduch Research Topics

Disease

7	Multiple Myeloma 12/2013 - 05/2006
5	Neoplasms (Cancer) 04/2017 - 10/2005
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2017 - 11/2002
3	Hodgkin Disease (Hodgkin's Disease) 05/2015 - 02/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 05/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2017 - 02/2008
2	Lymphoma (Lymphomas) 01/2014 - 02/2012
2	Leukemia 01/2014 - 04/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2012 - 02/2008
2	Pathologic Complete Response 02/2008 - 10/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008 - 07/2004
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005 - 09/2005
1	Disease Progression 01/2014
1	Blast Crisis (Blast Phase) 01/2014
1	Residual Neoplasm 12/2013
1	Melanoma (Melanoma, Malignant) 12/2013
1	Trisomy (Trisomies) 05/2011
1	Lung Neoplasms (Lung Cancer) 03/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2008
1	Adenocarcinoma 06/2008
1	Bronchiolitis Obliterans Syndrome 02/2008
1	Progressive Multifocal Leukoencephalopathy 02/2008
1	Meningioma (Meningiomas) 02/2008
1	Septic Shock (Toxic Shock Syndrome) 01/2006
1	Cytokine Release Syndrome 01/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2006
1	Shock 01/2006
1	Splenic Rupture 08/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2004
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2003
1	HIV Infections (HIV Infection) 04/2003
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2003
1	Infections 04/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2003

Drug/Important Bio-Agent (IBA)

3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017 - 02/2008
3	fludarabineIBA 04/2017 - 02/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 02/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015 - 08/2012
2	Gemcitabine FDA Link 01/2014 - 06/2008
2	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 03/2012
2	Melphalan (Alkeran)FDA LinkGeneric 08/2012 - 11/2010
2	AntigensIBA 02/2012 - 09/2005
2	Busulfan (Busulfex)FDA Link 11/2010 - 02/2008
2	Oleic Acid (Oleate)IBA 03/2010 - 10/2005
2	2-hydroxy-9-cis-octadecenoic acidIBA 03/2010 - 10/2005
2	Protein Kinase CIBA 03/2010 - 10/2005
2	Methotrexate (Mexate)FDA LinkGeneric 06/2008 - 02/2008
2	Rituximab (Mabthera)FDA Link 01/2006 - 11/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 05/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2015
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2015
1	Dacarbazine (DIC)FDA LinkGeneric 05/2015
1	bcr-abl Fusion ProteinsIBA 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	GelatinIBA 01/2014
1	CollagenIBA 01/2014
1	Laminin (Merosin)IBA 01/2014
1	ribonucleotide polymeraseIBA 12/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2012
1	Carmustine (FIVB)FDA Link 08/2012
1	Bortezomib (Velcade)FDA Link 08/2012
1	Prednisone (Sone)FDA LinkGeneric 08/2012
1	Vincristine (Oncovin)FDA LinkGeneric 08/2012
1	Thalidomide (Thalomid)FDA Link 08/2012
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2012
1	14-thioglycolamido-7,8-dihydromorphinone (TAMO)IBA 02/2012
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2011
1	Biomarkers (Surrogate Marker)IBA 05/2011
1	LipidsIBA 03/2010
1	AntimetabolitesIBA 06/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2008
1	purineIBA 02/2008
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2008
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2008
1	Alkylating AgentsIBA 05/2006
1	CytokinesIBA 01/2006
1	Interleukin-10 (Interleukin 10)IBA 01/2006
1	Antineoplastic Agents (Antineoplastics)IBA 10/2005
1	Olive OilIBA 10/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2004
1	AnthracyclinesIBA 07/2004
1	Alemtuzumab (Campath)FDA Link 05/2004

Therapy/Procedure

10	Therapeutics 04/2017 - 04/2003
6	Stem Cell Transplantation 02/2012 - 07/2004
6	Drug Therapy (Chemotherapy) 02/2012 - 04/2003
3	Transplantation 02/2012 - 02/2008
2	Hematopoietic Stem Cell Transplantation 07/2004 - 05/2003
1	Radiotherapy 05/2015
1	Homologous Transplantation 02/2012
1	Autologous Transplantation 11/2010
1	Maintenance Chemotherapy 10/2005